BIOFILCHEM Stock Overview
Manufactures and trades in pharmaceuticals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Biofil Chemicals and Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹59.20 |
| 52 Week High | ₹91.87 |
| 52 Week Low | ₹48.70 |
| Beta | 2.66 |
| 11 Month Change | -10.03% |
| 3 Month Change | -12.86% |
| 1 Year Change | 18.64% |
| 33 Year Change | -1.42% |
| 5 Year Change | 596.47% |
| Change since IPO | 157.95% |
Recent News & Updates
Recent updates
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 01
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Shares Climb 60% But Its Business Is Yet to Catch Up
Sep 18
There's Reason For Concern Over Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Price
Sep 03Getting In Cheap On Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM) Is Unlikely
Jul 18Shareholder Returns
| BIOFILCHEM | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -5.4% | -0.5% | -1.2% |
| 1Y | 18.6% | 41.6% | 25.5% |
Return vs Industry: BIOFILCHEM underperformed the Indian Pharmaceuticals industry which returned 41.6% over the past year.
Return vs Market: BIOFILCHEM underperformed the Indian Market which returned 25.5% over the past year.
Price Volatility
| BIOFILCHEM volatility | |
|---|---|
| BIOFILCHEM Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: BIOFILCHEM's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: BIOFILCHEM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 26 | Ramesh Shah | www.biofilgroup.net |
Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications.
Biofil Chemicals and Pharmaceuticals Limited Fundamentals Summary
| BIOFILCHEM fundamental statistics | |
|---|---|
| Market cap | ₹962.76m |
| Earnings (TTM) | ₹5.36m |
| Revenue (TTM) | ₹314.53m |
181.0x
P/E Ratio3.1x
P/S RatioIs BIOFILCHEM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOFILCHEM income statement (TTM) | |
|---|---|
| Revenue | ₹314.53m |
| Cost of Revenue | ₹289.55m |
| Gross Profit | ₹24.98m |
| Other Expenses | ₹19.62m |
| Earnings | ₹5.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 7.94% |
| Net Profit Margin | 1.70% |
| Debt/Equity Ratio | 2.5% |
How did BIOFILCHEM perform over the long term?
See historical performance and comparison